Date Log
To evaluate the awareness about human papilloma virus (HPV) vaccine in the prevention of cervical cancer amongst the medical students: A KAP study
Corresponding Author(s) : Sagar B Bhagat
International Journal of Allied Medical Sciences and Clinical Research,
Vol. 2 No. 4 (2014): 2014 Volume 2- Issue -4
Abstract
Cervical cancer is the fifth most common cancer in humans, the second most common cancer in women worldwide and the most common cancer cause of death in the developing countries like India. An observational, cross sectional, questionnaire based study conducted in Grant Govt. Medical College & Sir JJ Group of Hospital among 500 medical students of either sex who were either in II year or passed II year of their curriculum. 500 students participated in the study. 480 (96%) were aware of the causative agent of cervical cancer. 346(69.4%) participants were aware regarding the availability of vaccine against cervical cancer. 281(56.2%) of participants were aware that HPV Vaccine is available in India. Overall awareness regarding target population for HPV Vaccination was 138(27.6%). 319 (63.8%) participants knew by which route HPV Vaccine is administered and 187(37.4%) knew when is the vaccine most effective. Unfortunately only 30 (6%) participants were vaccinated. Most common source of information for our study population was electronic media 269(53.4%) such as internet. 398 (79.6%) participants thought most important problem is inadequate information. Only 176 (35.8%) participants thought HPV vaccine is needed for men also and 377(75.4%) participants believed that it is necessary to screen the vaccinated person also. Overall only 67.8% participants showed their acceptance for HPV vaccine. Majority of the participants were lacking knowledge about HPV vaccine in all aspects. Participants have reluctant attitude before onset of this study for this important topic & rarely do they practice it.
Keywords
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX
-
[1] Schiff man M, Castle PE, Geronimo J, Rodrigue AC, Wacholde S. Human papillomavirus and cervical cancer. Lancet. 2007; 370:890–907. [PubMed: 17826171]
[2] Sankaranarayanan R, Ferlay J. Worldwide burden of gynecological cancer: The size of the problem. Best Pract Res Clin Obstet Gynaecol. 2006; 20:207–25.[PubMed: 16359925]
[3] Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics. CA Cancer J Clin 2002. 55: 74–108.
[4] WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Summary report on HPV and cervical cancer statistics in India 2007. [Last Assessed on 2014 July 29]. Available from: http://www.who.int
/hpvcentre.
[5] Gonik B, Jones T, Fasano N, Contreras D, Roberts C. Vaccine preventable diseases (VPD): improving the obstetrician/gynecologists knowledge and immunication practice patterns. American Journal of Obstetrics and Gynecology 2001; 185: 162.
[6] Saha A, Nag Chaudhury A, Bhowmik P, Chatterjee R (2010) Awareness of Cervical Cancer Among Female Students of Premier Colleges in Kolkata, India. Asian Pacific Journal of Cancer Prevention 11: 1085–1090.
[7] Donders GG, Gabrovska M, Bellen G, Van Keirsbilck J, Van Den Bosch T, et al. Knowledge of cervix cancer, human papilloma virus (HPV) and HPV vaccination at the moment of introduction of the vaccine in women in Belgium. Arch Gynecol Obstet 2008; 277(4): 291–298.
[8] Mausumi B, Showket H, Vilas N, Bhudev CD. HPV & HPV vaccination: Issues in developing countries. Indian J Med Res 2009; 130: 327–333.
[9] Neerja B, Elizabeth J. Cervical cancer prevention & the role of human papillomavirus vaccines in India. Indian J Med Res 2009; 130: 334–340.
References
[2] Sankaranarayanan R, Ferlay J. Worldwide burden of gynecological cancer: The size of the problem. Best Pract Res Clin Obstet Gynaecol. 2006; 20:207–25.[PubMed: 16359925]
[3] Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics. CA Cancer J Clin 2002. 55: 74–108.
[4] WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Summary report on HPV and cervical cancer statistics in India 2007. [Last Assessed on 2014 July 29]. Available from: http://www.who.int
/hpvcentre.
[5] Gonik B, Jones T, Fasano N, Contreras D, Roberts C. Vaccine preventable diseases (VPD): improving the obstetrician/gynecologists knowledge and immunication practice patterns. American Journal of Obstetrics and Gynecology 2001; 185: 162.
[6] Saha A, Nag Chaudhury A, Bhowmik P, Chatterjee R (2010) Awareness of Cervical Cancer Among Female Students of Premier Colleges in Kolkata, India. Asian Pacific Journal of Cancer Prevention 11: 1085–1090.
[7] Donders GG, Gabrovska M, Bellen G, Van Keirsbilck J, Van Den Bosch T, et al. Knowledge of cervix cancer, human papilloma virus (HPV) and HPV vaccination at the moment of introduction of the vaccine in women in Belgium. Arch Gynecol Obstet 2008; 277(4): 291–298.
[8] Mausumi B, Showket H, Vilas N, Bhudev CD. HPV & HPV vaccination: Issues in developing countries. Indian J Med Res 2009; 130: 327–333.
[9] Neerja B, Elizabeth J. Cervical cancer prevention & the role of human papillomavirus vaccines in India. Indian J Med Res 2009; 130: 334–340.